Oximio in the Middle East

Through our GMP facility in Israel, GDP Depot in Türkiye and audited local Depot Partners in Egypt and Lebanon we provide access to 207 million patients of Middle East. With Oximio broad range of services and deep expertise, we are ready to tailor a supply strategy to fit your trial requirements.

Our Service Coverage in the Middle East:

Oximio Locations

Europe

Georgia

Hungary

Serbia

Ukraine

Partner Depot Moldova

Partner Depot Bosnia & Hercegovina

Partner Depot North Macedonia

North America

Partner Depot United States

Partner Depot Canada

Middle East

Israel

Türkiye

Partner Depot Egypt

Asia

Partner Depot India

Partner Depot China

Partner Depot Australia

Our Supply Chain Management team is ready to assist in defining optimal distribution strategy and support the needs of your next clinical study.